Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study
@article{TCR80017, author = {Luchun Li and Ting Wang and Zhijuan Wu and Yan Li and Huiwen Ma and Lulu Wang and Shuangyi Lei and Wen Chen}, title = {Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study}, journal = {Translational Cancer Research}, volume = {12}, number = {11}, year = {2023}, keywords = {}, abstract = {}, issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/80017} }